Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health, Halifax, Nova Scotia, Canada.
Department of Pathology, Dalhousie Universitygrid.55602.34, Halifax, Nova Scotia, Canada.
Microbiol Spectr. 2022 Feb 23;10(1):e0245521. doi: 10.1128/spectrum.02455-21. Epub 2022 Feb 16.
Containment measures employed during the COVID-19 pandemic included prompt recognition of cases, isolation, and contact tracing. Bilateral nasal (NA) swabs applied to a commercial antigen-based rapid diagnostic test (Ag-RDT) offer a simpler and more comfortable alternative to nasopharyngeal (NP) collection; however, little is known about the sensitivity of this method in an asymptomatic population. Participants in community-based asymptomatic testing sites were screened for SARS-CoV-2 using an Ag-RDT with NP sampling. Positive individuals returned for confirmatory molecular testing and consented to repeating the Ag-RDT using a bilateral NA swab for comparison. Residual test buffer (RTB) from Ag-RDTs was subjected to real-time reverse transcription-PCR (RT-PCR). Of 123,617 asymptomatic individuals, 197 NP Ag-RDT-positive participants were included, with 175 confirmed positive by RT-PCR. Of these cases, 154 were identified from the NA swab collection with Ag-RDT, with a sensitivity of 88.0% compared to the NP swab collection. Stratifying results by RT-PCR cycle threshold demonstrated that sensitivity of the nasal collection method varied based on the cycle threshold () value of the paired RT-PCR sample. RT-PCR testing on the RTB from the Ag-RDT using NP and NA swab collections resulted in 100.0% and 98.7% sensitivity, respectively. NA swabs provide an adequate alternative to NP swab collection for use with Ag-RDT, with the recognition that the test is most sensitive in specimens with high viral loads. With the high sensitivity of RT-PCR testing on RTB from Ag-RDT, a more streamlined approach to confirmatory testing is possible without recollection or use of paired collections strategies. Nasal swabbing for SARS-CoV-2 (COVID-19) comes with many benefits but is slightly less sensitive than traditional nasopharyngeal swabbing; however, confirmatory lab-based testing could be performed directly from the residual buffer from either sample type.
在 COVID-19 大流行期间采用的遏制措施包括及时识别病例、隔离和接触者追踪。双侧鼻腔(NA)拭子应用于商业抗原快速诊断检测(Ag-RDT)提供了一种更简单、更舒适的替代鼻咽(NP)采集方法;然而,对于无症状人群,这种方法的敏感性知之甚少。在社区无症状检测点的参与者使用 NP 采样的 Ag-RDT 进行 SARS-CoV-2 筛查。Ag-RDT 呈阳性的个体返回进行确认性分子检测,并同意重复使用双侧 NA 拭子进行比较的 Ag-RDT。Ag-RDT 的残留测试缓冲液(RTB)进行实时逆转录聚合酶链反应(RT-PCR)。在 123617 名无症状个体中,纳入了 197 名 NP Ag-RDT 阳性参与者,其中 175 名经 RT-PCR 确认为阳性。在这些病例中,154 例从 NA 拭子采集的 Ag-RDT 中被识别出来,与 NP 拭子采集相比,敏感性为 88.0%。按 RT-PCR 循环阈值对结果进行分层表明,鼻腔采集方法的敏感性取决于配对 RT-PCR 样本的循环阈值(Ct)值。使用 NP 和 NA 拭子采集对 Ag-RDT 的 RTB 进行 RT-PCR 检测,敏感性分别为 100.0%和 98.7%。NA 拭子为 Ag-RDT 提供了一种与 NP 拭子采集相当的替代方法,需要注意的是,该检测在病毒载量较高的标本中最敏感。由于 Ag-RDT 的 RTB 上的 RT-PCR 检测具有很高的敏感性,可以采用更简化的方法进行确认性检测,无需回忆或使用配对采集策略。对 SARS-CoV-2(COVID-19)进行鼻腔拭子检测有很多好处,但略低于传统的鼻咽拭子;然而,基于实验室的确认性检测可以直接从任何样本类型的残留缓冲液中进行。